Abstract
Introduction: Managing ARDS is resource-intensive, but published quantitative data are limited.
Objective: To examine the healthcare resource utilization (HRU) and costs of patients hospitalized with ARDS.
Methods: US administrative claims between 2009 and 2013 of commercially-insured individuals and Medicare beneficiaries were analyzed. Patients with ARDS who received mechanical ventilation during the index hospitalization were selected. Each ARDS patient was demographically matched to 10 non-ARDS hospitalized controls. HRU, costs, and comorbidities during one-year prior (baseline), were compared, as were characteristics of the index hospitalization. One-year HRU and costs of a subgroup who were discharged alive and had at least one year follow-up were also examined.
Results: Commercially-insured hospitalized ARDS patients had greater comorbid conditions and prior hospitalizations than matched controls. During the index hospitalization, ARDS patients had longer stays (16.7 vs. 4.6 days), higher mortality (11.9% vs. 0.8%), and incurred higher costs than controls ($117,137 vs. $25,199; all p<0.05). ARDS patients who survived to discharge were more likely to be re-hospitalized (53.2% vs. 12.9%) and incurred higher annual total costs ($82,749 vs. $22,670; both p<0.05) during the subsequent year. Trends were similar for Medicare beneficiaries.
Conclusion: Patients hospitalized with ARDS incurred significantly higher resource utilization and costs than non-ARDS hospitalizations during and prior to the stay. The pattern persists for one year after hospital discharge.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-2002
-
- There are more pages in this discussion • 15,856 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103162 | 0.970 |
5 | 34741 | 0.965 |
11 | 125566 | 0.960 |
1 | 500 | 0.955 |
22 | 165429 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.990 | 10204 | 1 |
1.000 | 14000 | 1 |
1.010 | 2877 | 1 |
1.015 | 60000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MSB (ASX) Chart |